Literature DB >> 7570430

Inhaled vasodilator therapy in acute lung injury: first, do NO harm?

S J Brett, T W Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7570430      PMCID： PMC474889          DOI： 10.1136/thx.50.8.821

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  35 in total

Review 1.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

2.  Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS.

Authors:  P Radermacher; Y Huet; F Pluskwa; R Herigault; H Mal; B Teisseire; F Lemaire
Journal:  Anesthesiology       Date:  1988-01       Impact factor: 7.892

3.  Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group.

Authors:  H J Silverman; G Slotman; R C Bone; R Maunder; T M Hyers; M D Kerstein; J J Ursprung
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

4.  Oxidant activity in expired breath of patients with adult respiratory distress syndrome.

Authors:  S R Baldwin; R H Simon; C M Grum; L H Ketai; L A Boxer; L J Devall
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

5.  Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. A light and electron microscopic study.

Authors:  C Hugod
Journal:  Int Arch Occup Environ Health       Date:  1979-01-15       Impact factor: 3.015

6.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.

Authors:  C G Frostell; H Blomqvist; G Hedenstierna; J Lundberg; W M Zapol
Journal:  Anesthesiology       Date:  1993-03       Impact factor: 7.892

8.  Prolonged bleeding time during nitric oxide inhalation in the rabbit.

Authors:  M Högman; C Frostell; H Arnberg; B Sandhagen; G Hedenstierna
Journal:  Acta Physiol Scand       Date:  1994-05

9.  Nitric oxide reversibly suppresses xanthine oxidase activity.

Authors:  M Fukahori; K Ichimori; H Ishida; H Nakagawa; H Okino
Journal:  Free Radic Res       Date:  1994-09

10.  Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.

Authors:  I Y Haddad; G Pataki; P Hu; C Galliani; J S Beckman; S Matalon
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808
View more
  2 in total

1.  UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS.

Authors:  B H Cuthbertson; P Dellinger; O J Dyar; T E Evans; T Higenbottam; R Latimer; D Payen; S A Stott; N R Webster; J D Young
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

Review 2.  NO: COPD and beyond.

Authors:  A T Jones; T W Evans
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.